Abbott Laboratories (ABT) Income Statement
Abbott Laboratories Income Statement
Last quarter (Q2 2026), Abbott Laboratories's total revenue was $12.59B, an increase of 13.02% from the same quarter last year. In Q2, Abbott Laboratories's net income was $928.00M. See Abbott Laboratories’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 44.33B | $ 41.95B | $ 40.11B | $ 43.65B | $ 43.08B | |
| $ 24.61B | $ 21.32B | $ 20.04B | $ 22.32B | $ 23.21B | |
| $ 16.59B | $ 14.47B | $ 13.60B | $ 13.96B | $ 14.01B | |
| Depreciation and Amortization | $ 3.12B | $ 3.22B | $ 3.24B | $ 3.27B | $ 3.54B |
| $ 11.92B | $ 10.83B | $ 10.61B | $ 11.89B | $ 12.16B | |
| $ 8.05B | $ 6.83B | $ 6.43B | $ 8.36B | $ 9.20B | |
| $ 418.00M | $ 188.00M | $ 229.00M | $ -56.00M | $ -989.00M | |
| $ 8.47B | $ 7.01B | $ 6.66B | $ 8.31B | $ 8.21B | |
| $ 6.52B | $ 13.40B | $ 5.72B | $ 6.93B | $ 7.07B | |
| Per Share Metrics | |||||
| Basic EPS | $ 3.74 | $ 7.67 | $ 3.30 | $ 3.94 | $ 3.97 |
| Diluted EPS | $ 3.72 | $ 7.64 | $ 3.27 | $ 3.91 | $ 3.94 |
| Weighted Average Shares Outstanding | 1.75B | 1.73B | 1.73B | 1.75B | 1.77B |
| Weighted Average Shares Outstanding (Diluted) | 1.75B | 1.75B | 1.75B | 1.76B | 1.79B |
Currency in USD